Denali Therapeutics Inc. DNLI Common stock, shares issued (in shares)
Common stock, shares issued (in shares) at other companies
Other financials
Where this comes from
Reported directly by Denali Therapeutics Inc. in its filing.
Tagged under the XBRL concept us-gaap:CommonStockSharesIssued.
The official record: Denali Therapeutics Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Denali Therapeutics Inc.'s common stock, shares issued (in shares).
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Denali Therapeutics Inc.'s common stock, shares issued (in shares)?
- Denali Therapeutics Inc. (DNLI) reported common stock, shares issued (in shares) of $158.66M in Q1 2026.
- How has Denali Therapeutics Inc.'s common stock, shares issued (in shares) changed year-over-year?
- Denali Therapeutics Inc.'s common stock, shares issued (in shares) increased by 9.2% year-over-year, from $145.25M to $158.66M.
- What is the long-term trend for Denali Therapeutics Inc.'s common stock, shares issued (in shares)?
- Over 5 years (2020 to 2025), Denali Therapeutics Inc.'s common stock, shares issued (in shares) has grown at a 5.3% compound annual growth rate (CAGR), from $120.53M to $156.18M.